nodes	percent_of_prediction	percent_of_DWPC	metapath
Acamprosate—GRIN2C—nerve—type 1 diabetes mellitus	0.0202	0.286	CbGeAlD
Acamprosate—GRIN2B—nerve—type 1 diabetes mellitus	0.016	0.226	CbGeAlD
Acamprosate—Psoriasis—Ramipril—type 1 diabetes mellitus	0.0159	0.0301	CcSEcCtD
Acamprosate—Neuralgia—Ramipril—type 1 diabetes mellitus	0.0144	0.0272	CcSEcCtD
Acamprosate—GRIN2A—nerve—type 1 diabetes mellitus	0.0139	0.198	CbGeAlD
Acamprosate—Laryngospasm—Ramipril—type 1 diabetes mellitus	0.0134	0.0253	CcSEcCtD
Acamprosate—Cough increased—Ramipril—type 1 diabetes mellitus	0.0109	0.0206	CcSEcCtD
Acamprosate—Creatinine increased—Ramipril—type 1 diabetes mellitus	0.0105	0.0199	CcSEcCtD
Acamprosate—Salivary hypersecretion—Ramipril—type 1 diabetes mellitus	0.00969	0.0184	CcSEcCtD
Acamprosate—Rash maculo-papular—Ramipril—type 1 diabetes mellitus	0.00907	0.0172	CcSEcCtD
Acamprosate—Urine output increased—Ramipril—type 1 diabetes mellitus	0.00902	0.0171	CcSEcCtD
Acamprosate—Polyuria—Ramipril—type 1 diabetes mellitus	0.00825	0.0156	CcSEcCtD
Acamprosate—Gastroenteritis—Ramipril—type 1 diabetes mellitus	0.00817	0.0155	CcSEcCtD
Acamprosate—Deafness—Ramipril—type 1 diabetes mellitus	0.0081	0.0153	CcSEcCtD
Acamprosate—Renal failure acute—Ramipril—type 1 diabetes mellitus	0.00785	0.0149	CcSEcCtD
Acamprosate—Libido decreased—Ramipril—type 1 diabetes mellitus	0.00781	0.0148	CcSEcCtD
Acamprosate—Amnesia—Ramipril—type 1 diabetes mellitus	0.00771	0.0146	CcSEcCtD
Acamprosate—Dermatitis exfoliative—Ramipril—type 1 diabetes mellitus	0.00768	0.0145	CcSEcCtD
Acamprosate—Arthritis—Ramipril—type 1 diabetes mellitus	0.00745	0.0141	CcSEcCtD
Acamprosate—Cardiac failure—Ramipril—type 1 diabetes mellitus	0.00742	0.0141	CcSEcCtD
Acamprosate—Hyponatraemia—Ramipril—type 1 diabetes mellitus	0.00727	0.0138	CcSEcCtD
Acamprosate—Disturbance in sexual arousal—Ramipril—type 1 diabetes mellitus	0.00719	0.0136	CcSEcCtD
Acamprosate—Blood creatinine increased—Ramipril—type 1 diabetes mellitus	0.00679	0.0128	CcSEcCtD
Acamprosate—Liver function test abnormal—Ramipril—type 1 diabetes mellitus	0.00669	0.0127	CcSEcCtD
Acamprosate—Orthostatic hypotension—Ramipril—type 1 diabetes mellitus	0.00662	0.0125	CcSEcCtD
Acamprosate—Breast disorder—Ramipril—type 1 diabetes mellitus	0.00655	0.0124	CcSEcCtD
Acamprosate—Gastritis—Ramipril—type 1 diabetes mellitus	0.00641	0.0121	CcSEcCtD
Acamprosate—Asthma—Ramipril—type 1 diabetes mellitus	0.00626	0.0119	CcSEcCtD
Acamprosate—Influenza—Ramipril—type 1 diabetes mellitus	0.00626	0.0119	CcSEcCtD
Acamprosate—Dysphagia—Ramipril—type 1 diabetes mellitus	0.00626	0.0119	CcSEcCtD
Acamprosate—Eosinophilia—Ramipril—type 1 diabetes mellitus	0.0062	0.0117	CcSEcCtD
Acamprosate—Pancreatitis—Ramipril—type 1 diabetes mellitus	0.00614	0.0116	CcSEcCtD
Acamprosate—Angina pectoris—Ramipril—type 1 diabetes mellitus	0.0061	0.0115	CcSEcCtD
Acamprosate—Bronchitis—Ramipril—type 1 diabetes mellitus	0.00602	0.0114	CcSEcCtD
Acamprosate—Erectile dysfunction—Ramipril—type 1 diabetes mellitus	0.00577	0.0109	CcSEcCtD
Acamprosate—Photosensitivity reaction—Ramipril—type 1 diabetes mellitus	0.00571	0.0108	CcSEcCtD
Acamprosate—Weight increased—Ramipril—type 1 diabetes mellitus	0.0057	0.0108	CcSEcCtD
Acamprosate—Acute coronary syndrome—Ramipril—type 1 diabetes mellitus	0.0055	0.0104	CcSEcCtD
Acamprosate—Myocardial infarction—Ramipril—type 1 diabetes mellitus	0.00547	0.0104	CcSEcCtD
Acamprosate—Stomatitis—Ramipril—type 1 diabetes mellitus	0.00544	0.0103	CcSEcCtD
Acamprosate—Urinary tract infection—Ramipril—type 1 diabetes mellitus	0.00543	0.0103	CcSEcCtD
Acamprosate—SLC36A1—nephron tubule—type 1 diabetes mellitus	0.00541	0.0766	CbGeAlD
Acamprosate—Sweating—Ramipril—type 1 diabetes mellitus	0.00535	0.0101	CcSEcCtD
Acamprosate—Epistaxis—Ramipril—type 1 diabetes mellitus	0.00526	0.00997	CcSEcCtD
Acamprosate—Hepatitis—Ramipril—type 1 diabetes mellitus	0.00501	0.00949	CcSEcCtD
Acamprosate—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.00494	0.00935	CcSEcCtD
Acamprosate—Visual impairment—Ramipril—type 1 diabetes mellitus	0.00483	0.00914	CcSEcCtD
Acamprosate—SLC36A1—kidney—type 1 diabetes mellitus	0.00475	0.0673	CbGeAlD
Acamprosate—SLC36A1—pancreas—type 1 diabetes mellitus	0.00472	0.0669	CbGeAlD
Acamprosate—Tinnitus—Ramipril—type 1 diabetes mellitus	0.00467	0.00885	CcSEcCtD
Acamprosate—Immune system disorder—Ramipril—type 1 diabetes mellitus	0.00453	0.00857	CcSEcCtD
Acamprosate—Alopecia—Ramipril—type 1 diabetes mellitus	0.00443	0.00838	CcSEcCtD
Acamprosate—Mental disorder—Ramipril—type 1 diabetes mellitus	0.00439	0.00831	CcSEcCtD
Acamprosate—Malnutrition—Ramipril—type 1 diabetes mellitus	0.00436	0.00826	CcSEcCtD
Acamprosate—Tension—Ramipril—type 1 diabetes mellitus	0.00428	0.00811	CcSEcCtD
Acamprosate—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.00427	0.00809	CcSEcCtD
Acamprosate—Nervousness—Ramipril—type 1 diabetes mellitus	0.00424	0.00802	CcSEcCtD
Acamprosate—Muscle spasms—Ramipril—type 1 diabetes mellitus	0.00419	0.00794	CcSEcCtD
Acamprosate—Tremor—Ramipril—type 1 diabetes mellitus	0.00409	0.00774	CcSEcCtD
Acamprosate—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.00405	0.00766	CcSEcCtD
Acamprosate—Agitation—Ramipril—type 1 diabetes mellitus	0.00401	0.00759	CcSEcCtD
Acamprosate—Angioedema—Ramipril—type 1 diabetes mellitus	0.00399	0.00755	CcSEcCtD
Acamprosate—Malaise—Ramipril—type 1 diabetes mellitus	0.00393	0.00745	CcSEcCtD
Acamprosate—Vertigo—Ramipril—type 1 diabetes mellitus	0.00392	0.00742	CcSEcCtD
Acamprosate—Syncope—Ramipril—type 1 diabetes mellitus	0.00391	0.00741	CcSEcCtD
Acamprosate—Leukopenia—Ramipril—type 1 diabetes mellitus	0.0039	0.00739	CcSEcCtD
Acamprosate—Palpitations—Ramipril—type 1 diabetes mellitus	0.00385	0.0073	CcSEcCtD
Acamprosate—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.00383	0.00726	CcSEcCtD
Acamprosate—Cough—Ramipril—type 1 diabetes mellitus	0.00381	0.00721	CcSEcCtD
Acamprosate—Convulsion—Ramipril—type 1 diabetes mellitus	0.00378	0.00716	CcSEcCtD
Acamprosate—Chest pain—Ramipril—type 1 diabetes mellitus	0.00371	0.00703	CcSEcCtD
Acamprosate—Myalgia—Ramipril—type 1 diabetes mellitus	0.00371	0.00703	CcSEcCtD
Acamprosate—Arthralgia—Ramipril—type 1 diabetes mellitus	0.00371	0.00703	CcSEcCtD
Acamprosate—Anxiety—Ramipril—type 1 diabetes mellitus	0.0037	0.00701	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.00369	0.00698	CcSEcCtD
Acamprosate—Discomfort—Ramipril—type 1 diabetes mellitus	0.00367	0.00695	CcSEcCtD
Acamprosate—Dry mouth—Ramipril—type 1 diabetes mellitus	0.00363	0.00688	CcSEcCtD
Acamprosate—Confusional state—Ramipril—type 1 diabetes mellitus	0.00359	0.0068	CcSEcCtD
Acamprosate—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.00356	0.00674	CcSEcCtD
Acamprosate—Shock—Ramipril—type 1 diabetes mellitus	0.0035	0.00663	CcSEcCtD
Acamprosate—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.00349	0.0066	CcSEcCtD
Acamprosate—Tachycardia—Ramipril—type 1 diabetes mellitus	0.00347	0.00658	CcSEcCtD
Acamprosate—Skin disorder—Ramipril—type 1 diabetes mellitus	0.00346	0.00655	CcSEcCtD
Acamprosate—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.00344	0.00652	CcSEcCtD
Acamprosate—Anorexia—Ramipril—type 1 diabetes mellitus	0.00339	0.00643	CcSEcCtD
Acamprosate—Hypotension—Ramipril—type 1 diabetes mellitus	0.00333	0.0063	CcSEcCtD
Acamprosate—GABRB3—islet of Langerhans—type 1 diabetes mellitus	0.00327	0.0463	CbGeAlD
Acamprosate—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.00324	0.00614	CcSEcCtD
Acamprosate—Insomnia—Ramipril—type 1 diabetes mellitus	0.00322	0.0061	CcSEcCtD
Acamprosate—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.0032	0.00605	CcSEcCtD
Acamprosate—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.00317	0.00601	CcSEcCtD
Acamprosate—Somnolence—Ramipril—type 1 diabetes mellitus	0.00316	0.00599	CcSEcCtD
Acamprosate—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.00313	0.00593	CcSEcCtD
Acamprosate—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.00309	0.00586	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.00307	0.00582	CcSEcCtD
Acamprosate—Constipation—Ramipril—type 1 diabetes mellitus	0.00304	0.00576	CcSEcCtD
Acamprosate—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.00293	0.00556	CcSEcCtD
Acamprosate—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.00291	0.00551	CcSEcCtD
Acamprosate—Urticaria—Ramipril—type 1 diabetes mellitus	0.00283	0.00536	CcSEcCtD
Acamprosate—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.00281	0.00533	CcSEcCtD
Acamprosate—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.00281	0.00533	CcSEcCtD
Acamprosate—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.00262	0.00497	CcSEcCtD
Acamprosate—GRIN1—Spinal Cord Injury—LGALS3—type 1 diabetes mellitus	0.00262	0.00653	CbGpPWpGaD
Acamprosate—GRIN2D—Transmission across Chemical Synapses—GAD1—type 1 diabetes mellitus	0.0026	0.00649	CbGpPWpGaD
Acamprosate—GRIN1—Alzheimers Disease—NOS1—type 1 diabetes mellitus	0.0026	0.00647	CbGpPWpGaD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—PRKCQ—type 1 diabetes mellitus	0.00256	0.00639	CbGpPWpGaD
Acamprosate—Asthenia—Ramipril—type 1 diabetes mellitus	0.00255	0.00484	CcSEcCtD
Acamprosate—GRIN2B—Alzheimers Disease—NOS1—type 1 diabetes mellitus	0.00253	0.00631	CbGpPWpGaD
Acamprosate—Pruritus—Ramipril—type 1 diabetes mellitus	0.00252	0.00477	CcSEcCtD
Acamprosate—SLC36A1—SLC-mediated transmembrane transport—CP—type 1 diabetes mellitus	0.0025	0.00623	CbGpPWpGaD
Acamprosate—SLC36A1—SLC-mediated transmembrane transport—SLC11A1—type 1 diabetes mellitus	0.00248	0.00618	CbGpPWpGaD
Acamprosate—GRIN2C—Neuronal System—GAD2—type 1 diabetes mellitus	0.00247	0.00617	CbGpPWpGaD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—GAD2—type 1 diabetes mellitus	0.00247	0.00614	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—GAL—type 1 diabetes mellitus	0.00246	0.00612	CbGpPWpGaD
Acamprosate—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.00244	0.00461	CcSEcCtD
Acamprosate—GRM5—GPCR ligand binding—CCL11—type 1 diabetes mellitus	0.00243	0.00605	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—CCL20—type 1 diabetes mellitus	0.00243	0.00605	CbGpPWpGaD
Acamprosate—Dizziness—Ramipril—type 1 diabetes mellitus	0.00235	0.00446	CcSEcCtD
Acamprosate—GRIN2D—Neuronal System—GAD2—type 1 diabetes mellitus	0.0023	0.00573	CbGpPWpGaD
Acamprosate—GABRB3—pancreas—type 1 diabetes mellitus	0.0023	0.0326	CbGeAlD
Acamprosate—GRM5—GPCR ligand binding—CHRM2—type 1 diabetes mellitus	0.00228	0.00569	CbGpPWpGaD
Acamprosate—Vomiting—Ramipril—type 1 diabetes mellitus	0.00226	0.00429	CcSEcCtD
Acamprosate—Rash—Ramipril—type 1 diabetes mellitus	0.00224	0.00425	CcSEcCtD
Acamprosate—Dermatitis—Ramipril—type 1 diabetes mellitus	0.00224	0.00425	CcSEcCtD
Acamprosate—GRIN2C—Neuronal System—KCNJ11—type 1 diabetes mellitus	0.00224	0.00558	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—CHRM2—type 1 diabetes mellitus	0.00223	0.00556	CbGpPWpGaD
Acamprosate—Headache—Ramipril—type 1 diabetes mellitus	0.00223	0.00422	CcSEcCtD
Acamprosate—GRIN2C—Neuronal System—SLC18A2—type 1 diabetes mellitus	0.00217	0.0054	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—ABCC8—type 1 diabetes mellitus	0.00216	0.00539	CbGpPWpGaD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—SLC18A2—type 1 diabetes mellitus	0.00216	0.00538	CbGpPWpGaD
Acamprosate—GRIN1—Transmission across Chemical Synapses—GAD2—type 1 diabetes mellitus	0.00215	0.00536	CbGpPWpGaD
Acamprosate—GRIN2C—Neuronal System—GAD1—type 1 diabetes mellitus	0.00215	0.00535	CbGpPWpGaD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—GAD1—type 1 diabetes mellitus	0.00214	0.00533	CbGpPWpGaD
Acamprosate—Nausea—Ramipril—type 1 diabetes mellitus	0.00211	0.004	CcSEcCtD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—GAD2—type 1 diabetes mellitus	0.0021	0.00522	CbGpPWpGaD
Acamprosate—GRIN2D—Neuronal System—KCNJ11—type 1 diabetes mellitus	0.00208	0.00518	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—G6PC2—type 1 diabetes mellitus	0.00208	0.00518	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—CACNA1G—type 1 diabetes mellitus	0.00205	0.00511	CbGpPWpGaD
Acamprosate—GRIN2D—Neuronal System—SLC18A2—type 1 diabetes mellitus	0.00202	0.00502	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—CACNA1G—type 1 diabetes mellitus	0.002	0.00498	CbGpPWpGaD
Acamprosate—GRIN2D—Neuronal System—GAD1—type 1 diabetes mellitus	0.00199	0.00497	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—IAPP—type 1 diabetes mellitus	0.00192	0.00478	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—GAD2—type 1 diabetes mellitus	0.00189	0.00471	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—ABCC8—type 1 diabetes mellitus	0.00189	0.0047	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—NOS1—type 1 diabetes mellitus	0.00188	0.00469	CbGpPWpGaD
Acamprosate—GRIN1—Transmission across Chemical Synapses—SLC18A2—type 1 diabetes mellitus	0.00188	0.00469	CbGpPWpGaD
Acamprosate—GRIN1—Transmission across Chemical Synapses—GAD1—type 1 diabetes mellitus	0.00186	0.00465	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—ABCC8—type 1 diabetes mellitus	0.00184	0.00458	CbGpPWpGaD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—SLC18A2—type 1 diabetes mellitus	0.00184	0.00458	CbGpPWpGaD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—GAD1—type 1 diabetes mellitus	0.00182	0.00453	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—ABCC8—type 1 diabetes mellitus	0.0018	0.00449	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—KCNJ11—type 1 diabetes mellitus	0.00171	0.00426	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—CXCL10—type 1 diabetes mellitus	0.00171	0.00426	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—SST—type 1 diabetes mellitus	0.00168	0.0042	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—ADRB1—type 1 diabetes mellitus	0.00168	0.00418	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—SLC18A2—type 1 diabetes mellitus	0.00165	0.00412	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—GAD2—type 1 diabetes mellitus	0.00165	0.00411	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—SST—type 1 diabetes mellitus	0.00164	0.0041	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—GAD1—type 1 diabetes mellitus	0.00164	0.00408	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—GAD2—type 1 diabetes mellitus	0.00161	0.004	CbGpPWpGaD
Acamprosate—GRIN2C—Alzheimers Disease—IL1B—type 1 diabetes mellitus	0.00159	0.00396	CbGpPWpGaD
Acamprosate—GRIN2C—Alzheimers Disease—CASP3—type 1 diabetes mellitus	0.00159	0.00395	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—GCG—type 1 diabetes mellitus	0.0015	0.00374	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—KCNJ11—type 1 diabetes mellitus	0.00149	0.00371	CbGpPWpGaD
Acamprosate—GRIN2D—Alzheimers Disease—IL1B—type 1 diabetes mellitus	0.00148	0.00369	CbGpPWpGaD
Acamprosate—GRIN2D—Alzheimers Disease—CASP3—type 1 diabetes mellitus	0.00148	0.00368	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—CACNA1G—type 1 diabetes mellitus	0.00146	0.00365	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—PAX4—type 1 diabetes mellitus	0.00146	0.00365	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—KCNJ11—type 1 diabetes mellitus	0.00145	0.00362	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—SLC18A2—type 1 diabetes mellitus	0.00144	0.0036	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—GAD1—type 1 diabetes mellitus	0.00143	0.00356	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—CACNA1G—type 1 diabetes mellitus	0.00143	0.00356	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—PAX4—type 1 diabetes mellitus	0.00143	0.00356	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—IL4—type 1 diabetes mellitus	0.00143	0.00355	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—GAD2—type 1 diabetes mellitus	0.00142	0.00354	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—E2F1—type 1 diabetes mellitus	0.00142	0.00353	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—SLC18A2—type 1 diabetes mellitus	0.00141	0.00351	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	0.0014	0.00349	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—GAD2—type 1 diabetes mellitus	0.00139	0.00347	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—GAD1—type 1 diabetes mellitus	0.00139	0.00347	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—GAL—type 1 diabetes mellitus	0.00139	0.00346	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—SLC18A2—type 1 diabetes mellitus	0.00138	0.00344	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	0.00137	0.00342	CbGpPWpGaD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—type 1 diabetes mellitus	0.00134	0.00333	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	0.00129	0.00322	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC29A3—type 1 diabetes mellitus	0.00127	0.00317	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	0.00127	0.00317	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—CHRM2—type 1 diabetes mellitus	0.00126	0.00315	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—GAL—type 1 diabetes mellitus	0.00126	0.00314	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	0.00126	0.00314	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC29A3—type 1 diabetes mellitus	0.00125	0.00311	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CCL11—type 1 diabetes mellitus	0.00125	0.00311	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CCL20—type 1 diabetes mellitus	0.00125	0.00311	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—HNF1A—type 1 diabetes mellitus	0.00125	0.0031	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—PDX1—type 1 diabetes mellitus	0.00125	0.0031	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—ABCC8—type 1 diabetes mellitus	0.00124	0.0031	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—SLC18A2—type 1 diabetes mellitus	0.00124	0.0031	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—GAD1—type 1 diabetes mellitus	0.00123	0.00307	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—ABCC8—type 1 diabetes mellitus	0.00122	0.00304	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—SLC18A2—type 1 diabetes mellitus	0.00122	0.00304	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—GAD2—type 1 diabetes mellitus	0.00122	0.00303	CbGpPWpGaD
Acamprosate—GRIN2A—Alzheimers Disease—IL1B—type 1 diabetes mellitus	0.00121	0.00303	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—HNF1A—type 1 diabetes mellitus	0.00121	0.00302	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—PDX1—type 1 diabetes mellitus	0.00121	0.00302	CbGpPWpGaD
Acamprosate—GRIN2A—Alzheimers Disease—CASP3—type 1 diabetes mellitus	0.00121	0.00302	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—GAD1—type 1 diabetes mellitus	0.00121	0.00301	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	0.00117	0.00292	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—IL10—type 1 diabetes mellitus	0.00117	0.00292	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	0.00116	0.00289	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—CDK4—type 1 diabetes mellitus	0.00116	0.00288	CbGpPWpGaD
Acamprosate—GRIN2C—Alzheimers Disease—TNF—type 1 diabetes mellitus	0.00115	0.00288	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—NOS2—type 1 diabetes mellitus	0.00112	0.0028	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC29A3—type 1 diabetes mellitus	0.00109	0.00272	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—GAD2—type 1 diabetes mellitus	0.00109	0.00271	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—CCR5—type 1 diabetes mellitus	0.00109	0.0027	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	0.00108	0.0027	CbGpPWpGaD
Acamprosate—GRIN2D—Alzheimers Disease—TNF—type 1 diabetes mellitus	0.00107	0.00267	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—GAD2—type 1 diabetes mellitus	0.00107	0.00266	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—ABCC8—type 1 diabetes mellitus	0.00107	0.00266	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—SLC18A2—type 1 diabetes mellitus	0.00107	0.00266	CbGpPWpGaD
Acamprosate—GRIN1—Alzheimers Disease—IL1B—type 1 diabetes mellitus	0.00106	0.00264	CbGpPWpGaD
Acamprosate—GRIN1—Alzheimers Disease—CASP3—type 1 diabetes mellitus	0.00106	0.00263	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—GAD1—type 1 diabetes mellitus	0.00106	0.00263	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	0.00105	0.00262	CbGpPWpGaD
Acamprosate—GRIN2B—Alzheimers Disease—IL1B—type 1 diabetes mellitus	0.00103	0.00257	CbGpPWpGaD
Acamprosate—GRIN2B—Alzheimers Disease—CASP3—type 1 diabetes mellitus	0.00103	0.00257	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.000985	0.00245	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—KCNJ11—type 1 diabetes mellitus	0.000983	0.00245	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—KCNJ11—type 1 diabetes mellitus	0.000965	0.00241	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—SLC18A2—type 1 diabetes mellitus	0.000952	0.00237	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.000952	0.00237	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.000948	0.00236	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—GAD1—type 1 diabetes mellitus	0.000943	0.00235	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—SLC18A2—type 1 diabetes mellitus	0.000935	0.00233	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—GAD2—type 1 diabetes mellitus	0.000933	0.00232	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—SST—type 1 diabetes mellitus	0.000931	0.00232	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—GAD1—type 1 diabetes mellitus	0.000926	0.00231	CbGpPWpGaD
Acamprosate—SLC36A1—SLC-mediated transmembrane transport—ALB—type 1 diabetes mellitus	0.000893	0.00222	CbGpPWpGaD
Acamprosate—GRIN2A—Alzheimers Disease—TNF—type 1 diabetes mellitus	0.000881	0.0022	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—SST—type 1 diabetes mellitus	0.000864	0.00215	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—IFNG—type 1 diabetes mellitus	0.000862	0.00215	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.000861	0.00214	CbGpPWpGaD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 1 diabetes mellitus	0.000851	0.00212	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.000848	0.00211	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—KCNJ11—type 1 diabetes mellitus	0.000844	0.0021	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—SLC18A2—type 1 diabetes mellitus	0.000817	0.00204	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.000817	0.00203	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—GAD1—type 1 diabetes mellitus	0.000809	0.00202	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.000793	0.00198	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.000791	0.00197	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—PRKCQ—type 1 diabetes mellitus	0.000786	0.00196	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—G6PC2—type 1 diabetes mellitus	0.000771	0.00192	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.00077	0.00192	CbGpPWpGaD
Acamprosate—GRIN1—Alzheimers Disease—TNF—type 1 diabetes mellitus	0.000769	0.00192	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—IL1B—type 1 diabetes mellitus	0.000769	0.00191	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—CASP3—type 1 diabetes mellitus	0.000767	0.00191	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—PRKCQ—type 1 diabetes mellitus	0.000767	0.00191	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—IL2—type 1 diabetes mellitus	0.000766	0.00191	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—G6PC2—type 1 diabetes mellitus	0.000757	0.00189	CbGpPWpGaD
Acamprosate—GRIN2B—Alzheimers Disease—TNF—type 1 diabetes mellitus	0.000749	0.00187	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000745	0.00186	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—IAPP—type 1 diabetes mellitus	0.000745	0.00186	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.000742	0.00185	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000737	0.00184	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000737	0.00184	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—IAPP—type 1 diabetes mellitus	0.000726	0.00181	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.00072	0.00179	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000718	0.00179	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000693	0.00173	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ABCC8—type 1 diabetes mellitus	0.000669	0.00167	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL10—type 1 diabetes mellitus	0.000664	0.00165	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—G6PC2—type 1 diabetes mellitus	0.000662	0.00165	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ABCC8—type 1 diabetes mellitus	0.000657	0.00164	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—CASP3—type 1 diabetes mellitus	0.000654	0.00163	CbGpPWpGaD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 1 diabetes mellitus	0.000654	0.00163	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—CASP3—type 1 diabetes mellitus	0.000637	0.00159	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000622	0.00155	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—IL1B—type 1 diabetes mellitus	0.000615	0.00153	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000613	0.00153	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—CASP3—type 1 diabetes mellitus	0.000613	0.00153	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000605	0.00151	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—EGFR—type 1 diabetes mellitus	0.000586	0.00146	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000585	0.00146	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000582	0.00145	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000582	0.00145	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ABCC8—type 1 diabetes mellitus	0.000574	0.00143	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—PRKCQ—type 1 diabetes mellitus	0.000561	0.0014	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—TNF—type 1 diabetes mellitus	0.000558	0.00139	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000557	0.00139	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—STAT3—type 1 diabetes mellitus	0.000549	0.00137	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000549	0.00137	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—PRKCQ—type 1 diabetes mellitus	0.000547	0.00136	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—STAT3—type 1 diabetes mellitus	0.000536	0.00133	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC18A2—type 1 diabetes mellitus	0.000512	0.00128	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—SST—type 1 diabetes mellitus	0.000511	0.00127	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000508	0.00127	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC18A2—type 1 diabetes mellitus	0.000503	0.00125	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	0.000471	0.00117	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	0.000467	0.00116	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	0.000463	0.00115	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	0.000459	0.00114	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000455	0.00113	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	0.000454	0.00113	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—IL6—type 1 diabetes mellitus	0.00045	0.00112	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—TNF—type 1 diabetes mellitus	0.000446	0.00111	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC18A2—type 1 diabetes mellitus	0.000439	0.00109	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000438	0.00109	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—CASP3—type 1 diabetes mellitus	0.000431	0.00107	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000426	0.00106	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000424	0.00106	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—TYK2—type 1 diabetes mellitus	0.00041	0.00102	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	0.000404	0.00101	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	0.000401	0.000999	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—TYK2—type 1 diabetes mellitus	0.0004	0.000996	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000387	0.000964	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000385	0.00096	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000371	0.000924	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—CDK4—type 1 diabetes mellitus	0.000368	0.000916	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—STAT3—type 1 diabetes mellitus	0.000362	0.000903	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—IL6—type 1 diabetes mellitus	0.00036	0.000897	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—CDK4—type 1 diabetes mellitus	0.000358	0.000893	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.000354	0.000883	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000352	0.000877	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL1B—type 1 diabetes mellitus	0.000348	0.000867	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—CASP3—type 1 diabetes mellitus	0.000347	0.000865	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000335	0.000834	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000329	0.00082	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—INS—type 1 diabetes mellitus	0.000328	0.000816	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000324	0.000808	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.000322	0.000802	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—INS—type 1 diabetes mellitus	0.000319	0.000796	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—TYK2—type 1 diabetes mellitus	0.000293	0.000729	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—TYK2—type 1 diabetes mellitus	0.000285	0.000711	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000271	0.000674	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—EGFR—type 1 diabetes mellitus	0.000261	0.00065	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—INS—type 1 diabetes mellitus	0.000256	0.000637	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—EGFR—type 1 diabetes mellitus	0.000254	0.000634	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—TNF—type 1 diabetes mellitus	0.000253	0.000629	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.000247	0.000616	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—EGFR—type 1 diabetes mellitus	0.000246	0.000613	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.000228	0.000569	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.000224	0.000559	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—STAT3—type 1 diabetes mellitus	0.000205	0.000511	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL6—type 1 diabetes mellitus	0.000204	0.000508	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—IL6—type 1 diabetes mellitus	0.000201	0.0005	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—STAT3—type 1 diabetes mellitus	0.0002	0.000498	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—IL6—type 1 diabetes mellitus	0.000196	0.000487	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CASP3—type 1 diabetes mellitus	0.00019	0.000474	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL2—type 1 diabetes mellitus	0.00019	0.000474	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IL6—type 1 diabetes mellitus	0.000189	0.000471	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—EGFR—type 1 diabetes mellitus	0.000186	0.000464	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—EGFR—type 1 diabetes mellitus	0.000182	0.000452	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—TNF—type 1 diabetes mellitus	0.000177	0.000442	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—TNF—type 1 diabetes mellitus	0.000173	0.000431	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	0.000168	0.000419	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	0.000165	0.000412	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—STAT3—type 1 diabetes mellitus	0.00016	0.000399	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—EGFR—type 1 diabetes mellitus	0.000145	0.000362	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	0.000144	0.00036	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—IL6—type 1 diabetes mellitus	0.000143	0.000357	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—IL6—type 1 diabetes mellitus	0.00014	0.000348	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL6—type 1 diabetes mellitus	0.000112	0.000278	CbGpPWpGaD
